J3401
HCPCSVyjuvek 5x10^9pfu/ml, 0.1 ml
Official HCPCS Level II long descriptor
Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
HCPCS Level II code J3401 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Vyjuvek 5x10^9pfu/ml, 0.1 ml
Added to HCPCS: 2024-01-01
Nearby codes in J3
- J3391Inj, atidarsagene autotemcel
- J3392Inj, exagamglogene autotem
- J3393Inj, betibeglogene autotemce
- J3394Inj, lovotibeglogene autotem
- J3396Verteporfin injection
- J3397Inj., vestronidase alfa-vjbk
- J3398Inj luxturna 1 billion vec g
- J3399Inj onase abepar-xioi treat
- J3402Inj. remestemcel-l-rknd/ td
- J3403Revakinagene, per implant
- J3404Inj zopapogene per ther dose
- J3405Inj onase abepar-brve treat
- J3410Hydroxyzine hcl injection
- J3411Thiamine hcl 100 mg
- J3415Pyridoxine hcl 100 mg
- J3420Vitamin b12 injection
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.